U.S. lifts ban on laboratory-made lethal viruses

December 19, 2017

(HealthDay)—U.S. officials said on Tuesday they've lifted a moratorium enacted three years ago on funding lab experiments that would create lethal viruses.

This type of research can now occur if a scientific panel finds the potential benefits outweigh any risks, said Dr. Francis Collins, head of the U.S. National Institutes of Health.

The research in question would involve tweaking viruses to make them more lethal.

Proponents of this type of science say it could give answers to urgent questions, such as how bird flu might mutate to infect humans more easily, or insights into vaccine development.

But opponents worry that scientists might inadvertently create a highly lethal germ that could escape the lab and infect humans worldwide.

Speaking to The New York Times, Collins said the new policy seeks to further science—but only when it's justified, and only in a high-security lab.

"We see this as a rigorous policy, we want to be sure we're doing this right," he said.

The new rules require that researchers show their studies are sound, and that any germ that might be modified in the lab would bring about knowledge that would benefit people—advances such as a vaccine, for example.

Scientists must also prove that there is no safer means of achieving that scientific end.

In October 2014, federal funding was stopped for lab research that would have altered three viruses to make them more lethal: the influenza ; the virus behind Middle East respiratory syndrome (MERS) and the virus behind severe acute respiratory syndrome (SARS).

The new regulations would allow such work, as well as other research, Collins said. According to the Times, that could theoretically include any request to create an Ebola virus that might be transmittable through the air.

Collins said the 2014 moratorium has halted 21 research projects, although 10 were later continued after being given exceptions to the rule.

Richard Ebright, a molecular biologist and bioweapons expert at Rutgers University in New Jersey, has long been a critic of this type of research. He told the Times that while he supports the use of review panels in greenlighting this research, he would prefer they be independent panels, not governmental boards.

Marc Lipsitch, who directs the Center for Communicable Disease Dynamics at the Harvard School of Public Health, was similarly cautious.

He said the implementation of the review process was "a small step forward." But he told the Times that lab work that has enhanced germs, "have given us some modest scientific knowledge and done almost nothing to improve our preparedness for pandemics, and yet risked creating an accidental pandemic."

Explore further: Researchers combine MERS and rabies viruses to create innovative 2-for-1 vaccine

More information: Find out more about pandemic viruses at the World Health Organization.

Related Stories

Researchers combine MERS and rabies viruses to create innovative 2-for-1 vaccine

December 7, 2016
In a new study, researchers have modified a rabies virus, so that it has a protein from the MERS virus; this altered virus works as a 2-for-1 vaccine that protects mice against both Middle East Respiratory Syndrome (MERS) ...

New experimental vaccine produces immune response against MERS virus

April 30, 2014
The University of Maryland School of Medicine (UM SOM) and Novavax, Inc. today announced that an investigational vaccine candidate developed by Novavax against the recently emerged Middle East Respiratory Syndrome Coronavirus ...

What exactly is coronavirus?

January 30, 2015
The conflicts in Syria and Iraq are straining public health systems and public health efforts meant to prevent and detect the spread of infectious diseases. This is generating a "perfect storm" of conditions for outbreaks. ...

Studies showing how bird flu viruses could adapt to humans offer surveillance and vaccine strategies

June 6, 2013
Bird flu viruses are potentially highly lethal and pose a global threat, but relatively little is known about why certain strains spread more easily to humans than others. Two studies published today in the journal Cell identify ...

Scientists identify two mutations critical for MERS transmission from bats to humans

June 11, 2015
Researchers have identified two critical mutations allowing the deadly Middle East Respiratory Syndrome (MERS) virus to transmit from bats to humans. The findings were published in the most recent edition of the Journal of ...

Saudi Arabia: Deaths from MERS virus reach 348

November 26, 2014
Saudi Arabia's Health Ministry says that a total of 348 people have died in the kingdom after contracting Middle East Respiratory Syndrome or MERS.

Recommended for you

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

Autoimmunity plays role in development of COPD, study finds

August 16, 2018
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information ...

Scientists identify nearly 200 potential tuberculosis drug targets

August 16, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

Reliable point-of-care blood test can help prevent toxoplasmosis

August 16, 2018
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy—and many other potential applications—is 100 percent sensitive ...

First mouse model to mimic lung disease could speed discovery of more effective treatments

August 16, 2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability ...

Anticancer drug offers potential alternative to transplant for patients with liver failure

August 15, 2018
Patients suffering sudden liver failure could in the future benefit from a new treatment that could reduce the need for transplants, research published today shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.